Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "This action continues a troubling pattern ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
“The FTC’s administrative action seeks to put an end to the Big Three PBMs’ exploitative conduct and marks an important step ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
MedPage Today on MSN22h
FTC Sues Top Pharmacy Benefit Managers Over Insulin PricesThe federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
That same month, the FTC published a report describing PBMs as powerful middlemen who “may be profiting by inflating drug ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback